Good results for early treatment of clinically isolated syndrome prior to multiple sclerosis with interferon beta-1b and glatiramer group

Author： Doggrell Sheila A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1225-1230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interferon-β1b for the treatment of multiple sclerosis

By Lam Sum   Wang Shan   Gottesman Malcolm  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1111-1117

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β1b in the treatment of multiple sclerosis

By Río Jordi   Montalban Xavier  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 16, 2005-12 ,pp. : 2877-2886

Informa Healthcare

Access to resources Recommend Favorite

Interferon-β-1b of benefit in early multiple sclerosis

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Glatiramer acetate for the treatment of multiple sclerosis

By Wolinsky Jerry S  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 875-891

Informa Healthcare

Access to resources Recommend Favorite

Glatiramer acetate in the treatment of multiple sclerosis

By Sela Michael   Teitelbaum Dvora  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1149-1165

Informa Healthcare

Access to resources Recommend Favorite